“Rosana Barbosa, mother of little 4-year-old Olivia, shared her story with Purodiol with us. Her daughter completed a year without seizures. Play and check your testimonial.”
The subtitles are not 100% accurate, but close enough to understand the gist of what she is saying.
In 2017/18, Isodiolex, Purodiol, and Isoderm received approval from Brazilian Health Regulatory Agency (Anvisa) for the treatment of Epilepsy and Parkinson’s disease. In addition, these products have been placed on the Special Category List for alternative therapies which will enable it to be prescribed by doctors and neurologists. For more information about ANVISA, here is their website.